Constellation Software Inc. (TSX:CSU) HOLD
Constellation Software is one of the world's best capital allocators, and on cash earnings it trades at about fifteen times with a very low PEG after a forty-five per cent drawdown. But the tape hasn't turned — the monthly and weekly trends are still down and the price sits below the 200-day — so the short-term call is a HOLD: buy on confirmation. On the medium and long horizons it stays a BUY.
Re-presenting the Donatien Investment report on Constellation Software (TSX:CSU), dated 20 July 2026, at C$2,780. Short-term HOLD; medium and long BUY.
An elite capital allocator
Constellation buys dozens of small, mission-critical software companies every year at disciplined prices, run through a highly decentralised structure, and compounds the cash they throw off into more acquisitions. Its track record of high returns on invested capital is legendary, and it keeps unlocking value through spin-offs like Topicus and Lumine. This is one of the best capital-allocation machines in public markets, diversified across thousands of sticky software niches, and none of that has changed this quarter.
Cheap on cash earnings
Here is why the medium and long call is a buy. The trailing reported price-to-earnings looks high near fifty-five times, but that is distorted by acquired-intangible amortisation, a non-cash charge inherent to the acquisitive model. On the cash earnings the business actually generates, the multiple is about fifteen times, with a PEG of just over a half and a free-cash-flow yield near six and a half per cent — genuinely cheap for a twenty-per-cent compounder, especially after a forty-five per cent drawdown. The Street is strong-buy with roughly forty per cent upside to consensus.
Why the short call is a HOLD
So why not buy it today. Because the tape has not confirmed. The monthly and weekly trends are still down and the price sits below its 200-day average, around two thousand nine hundred and thirty Canadian dollars. On the framework a cheap valuation alone is a half-size case; a short-term buy also needs the technical or catalyst path to open, and neither has. So the short-term signal is capped at HOLD — accumulate on weakness or on a confirmed reclaim of the 200-day, rather than chase. The medium and long horizons stay a buy because the compounding case is intact.
What could go wrong
Bearish tape: below the 200-day, could retest C$2,196. Capital deployment gets harder as size grows. A broad, lasting software-multiple de-rating.
Risk vs Reward
The report weights three twelve-month paths with a positive skew. The base case — most likely at fifty-five per cent — sees Constellation around three thousand eight hundred Canadian dollars as compounding continues and the cash multiple partly re-rates toward the analyst consensus, about thirty-seven per cent above today. The bull case at twenty-five per cent reaches four thousand seven hundred if deployment returns hold and spin-off optionality is recognised. The bear at twenty per cent takes it to two thousand two hundred if returns compress or software de-rates — a retest of the low.
The verdict
The bottom line: an elite capital allocator on sale, but caught in a downtrend. At about fifteen times cash earnings after a forty-five per cent drawdown, the medium and long call is a buy. The short-term call is a HOLD only because the tape has not turned — monthly and weekly trends still down, price below the 200-day. So this is a hold now; accumulate on weakness for the longer term, and buy the short case on a confirmed reclaim of the 200-day. Watch deployment returns as the business grows.
Read the full report on donatien.ca →
